Chalcones as Potential Ligands for the Treatment of Parkinson's Disease
Along with the increase in life expectancy, a significant increase of people suffering from neurodegenerative diseases (ND) has been noticed. The second most common ND, after Alzheimer's disease, is Parkinson's disease (PD), which manifests itself with a number of motor and non-motor sympt...
Saved in:
Main Authors: | Ewelina Królicka (Author), Katarzyna Kieć-Kononowicz (Author), Dorota Łażewska (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Targeting Ligands-Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity-In Vitro and In Vivo Evaluation
by: Dorota Łażewska, et al.
Published: (2022) -
The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats
by: Alaa Alachkar, et al.
Published: (2017) -
Effects of the DL76 Antagonist/Inverse Agonist of Histamine H<sub>3</sub> Receptors on Experimental Periodontitis in Rats: Morphological Studies
by: Mariusz Geremek, et al.
Published: (2024) -
Efficacy of the Multi-Target Compound E153 in Relieving Pain and Pruritus of Different Origins
by: Szczepan Mogilski, et al.
Published: (2023) -
Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions
by: Bijo Mathew, et al.
Published: (2021)